OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206

NCT00112086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Neoplasms
Fallopian Tube Neoplasms
Peritoneal Neoplasms

Interventions

DRUG: Neoadjuvant chemotherapy (Paclitaxel and Carboplatin)

Sponsor

Japan Clinical Oncology Group

Collaborators

[object Object]